glp-1 roche Ad hoc announcement pursuant to Art. 53 LR] announces positive Phase I results of its oral receptor agonist CT-996 for the treatment of people with obesity Can Swiss pharma giant Roche

Regulatory status: BPC-157 is not an approved human medicinal product in any regulatory zone (FDA, EMA, KL)

Alpha-cell paracrine signaling in the regulation of beta-cell insulin secretion

Kidney Dialysis Kidney Dialysis firms DaVita and Fresenius expect a modest headwind over time from the increasing adoption of these new GLP-1 drugs, but less than a 1% revenue impact per year

A pilot study investigating copper tripeptide topicals for aged skin found they increased skin thickness, improved hydration, boosted collagen synthesis, and increased elasticity

Functional improvements generally become noticeable during weeks 2 to 4